title: Changes in resistance to mouth opening induced by depolarizing and non-depolarizing neuromuscular relaxants.
abstract: Mouth opening was measured in 43 children anaesthetized with isoflurane and paralysed with vecuronium or suxamethonium. Measurements of mouth opening were made for up to 10 min after loss of the adductor pollicis twitch and cessation of muscle fasciculations. In 22 patients receiving suxamethonium, a significant (P less than 0.001) reduction in mean mouth opening occurred in the 60 s after loss of twitch and cessation of fasciculations. Mouth opening reductions could last for up to 10 min after the loss of twitch, beyond the return of the twitch. One patient experienced "masseter spasm"; he did not develop malignant hyperpyrexia during 2.5 h of isoflurane anaesthesia. Patients receiving vecuronium showed a significant (P less than 0.0006) increase in mouth opening. In 20 subjects, mouth opening was generated with a small (1.67 N) and a larger (4.32 N) force. Proportionally equal reductions in mouth opening were obtained with either force after suxamethonium administration. Relatively equal increases with either force followed vecuronium administration. Isolated masseter spasm is not pathognomonic for malignant hyperpyrexia. If the diagnosis of malignant hyperpyrexia is contemplated, signs of hypermetabolism, such as increases in end-tidal carbon dioxide concentration during constant minute ventilation, should be sought.
authors.affiliation: Department of Anesthesiology, University of Michigan, Ann Arbor 48109.
authors.forename: A F
authors.initials: AF
authors.lastname: van der Spek
authors.forename: P I
authors.initials: PI
authors.lastname: Reynolds
authors.forename: W B
authors.initials: WB
authors.lastname: Fang
authors.forename: J A
authors.initials: JA
authors.lastname: Ashton-Miller
authors.forename: C S
authors.initials: CS
authors.lastname: Stohler
authors.forename: M A
authors.initials: MA
authors.lastname: Schork
mesh_terms: D000704:Analysis of Variance; D000769:Anesthesia, Inhalation; D002648:Child; D005152:Facial Muscles / Q000187:drug effects; D005260:Female; D006801:Humans; D007530:Isoflurane; D008297:Male; D009055:Mouth / Q000502:physiology*; D009068:Movement / Q000187:drug effects; D009126:Muscle Relaxation / Q000187:drug effects; D013390:Succinylcholine / Q000494:pharmacology*; D014673:Vecuronium Bromide / Q000494:pharmacology*
chemical_list: D014673:Vecuronium Bromide; D007530:Isoflurane; D013390:Succinylcholine